The  logo

Clinical Pharmacist (May 2009)

Clinical Pharmacist (May 2009)Clinical Pharmacist

CP 2009;1:201-248

May 2009

Other issues

Previous

Next

Back issues

Opinion

We must collaborate to deliver a bright future
C Duggan
CP 2009;1:202

Editor’s choice

Who should be able to practise
M Wright
CP 2009;1:202

Update

Knowledge of when to start HIV drugs expands
CP 2009;1:205

Statins cut stroke risk but LDL cholesterol lowering needs further research
CP 2009;1:205 

Zoledronic acid prevents bone loss but not fractures for steroid patients
CP 2009;1:206

Study questions the use of ARBs to prevent AF
CP 2009;1:206

Clopidogrel and aspirin beneficial when anticoagulants not tolerated
CP 2009;1:206

Study reports increased leukaemia risk with mitoxantrone
CP 2009;1:206

Nsaids dementia protection questioned
CP 2009;1:206

News feature

Incentives for patients: what new research could reveal
G Malson
CP 2009;1:208-209

Correspondence

Management of breakthrough pain
S Simpson, K Groves, C Finnegan
CP 2009;1:210

Clinical focus

Osteoporosis: features of disease and diagnosis
C Copeland, A Worsley
CP 2009;1:211-215

Osteoporosis: treatment and risk assessment
W Baqir, C Copeland, A Worsley
CP 2009;1:216-223

Lifelong Learning
CP 2009;1:224 

Supplement

Award-winning abstracts from the UKCPA autumn symposium 2008
CP 2009;1:S1-S8  

Practice tools

How to avoid the pitfalls associated with continuous IV insulin infusions
E Hackett
CP 2009;1:225-226

Spotlight on medicines

Ivabradine
M Sani
CP 2009;1:229-232

Columnist

Reflections of an independent prescriber
M Hook
CP 2009;1:234

In the clinic

Pharmacist and nurse combine skills to assess people who fall
K Holden
CP 2009;1:235-237

Case report

Wilson’s disease: a complex picture
V Lee, E Morgan, J Kitley
CP 2009;1:239-241

FAQ

Alcohol consumption during low-dose weekly methotrexate therapy
CP 2009;1:242

Meeting

European Association of Hospital Pharmacists 2009 14th annual congress
L Taheri
CP 2009;1:243-244